文献速递心脑血管急症

亚洲房颤患者的终生风险、预测数量与不良结局:台湾全国房颤队列研究报告

Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study.
PubMed 文献 · Chest · 2017-10-07
一句话结论台湾全国队列显示≥20岁人群房颤终生风险约1/7,房颤患者死亡、心衰、缺血性卒中、痴呆、心源性猝死及心梗风险均显著高于无房颤者。

该研究基于台湾2000至2011年289,559例新发房颤患者,计算发病率、患病率及终生风险,并与年龄性别匹配的无房颤患者比较不良事件风险。2011年房颤发病率为1.51/1000人年,>20岁人群终生风险约1/7,预测2050年患病率4.01%。房颤患者死亡(aHR 2.61)、心衰(aHR 3.31)、缺血性卒中(aHR 3.34)、痴呆(aHR 1.56)、心源性猝死(aHR 1.83)及心梗(aHR 1.62)风险均显著升高(均P<.01)。缺血性卒中、心衰和死亡风险在首次诊断房颤后约6个月内尤其更高。作者认为优化相关合并症管理应作为房颤整体管理的一部分。

要点

  • ≥20岁亚洲人群房颤终生风险约1/7,预测2050年患病率达4.01%。
  • 与无房颤者相比,房颤患者死亡aHR 2.61、心衰aHR 3.31、缺血性卒中aHR 3.34,均P<.01。
  • 房颤患者痴呆aHR 1.56、心源性猝死aHR 1.83、心梗aHR 1.62,均P<.01。
  • 首次诊断房颤后约6个月内,缺血性卒中、心衰和死亡风险尤其高于无房颤者。

适用人群与场景

  • 台湾2000至2011年新发房颤、年龄≥20岁的患者289,559例;对照为年龄和性别匹配的无房颤患者。

研究设计与关键结果

  • 研究类型为全国性队列研究,纳入2000至2011年台湾289,559例年龄≥20岁新发房颤患者,对照为年龄和性别匹配的无房颤患者。
  • 2011年房颤发病率为1.51/1000人年,>20岁人群终生风险约1/7,预测2050年患病率4.01%。
  • 与无房颤患者相比,房颤患者死亡风险aHR 2.61、心衰aHR 3.31、缺血性卒中aHR 3.34、痴呆aHR 1.56、心源性猝死aHR 1.83、心梗aHR 1.62,均P<.01。
  • 首次诊断房颤后约6个月内,缺血性卒中、心衰和死亡风险尤其高于无房颤患者。

证据类型、等级与局限

  • 证据类型:全国性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,优化任何相关合并症的管理应作为房颤整体管理方法的一部分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Most data on the clinical epidemiology of atrial fibrillation (AF) come from Western populations, and data for Asians are limited. We investigated the lifetime risk and projected number of AF among Asians. The annual risks of adverse events among patients with AF, time trends, and the risks compared with patients without AF were analyzed.

METHODS: Between 2000 and 2011, 289,559 patients aged ≥ 20 years experienced new-onset AF in Taiwan. The incidence, prevalence, and lifetime risk of AF were calculated. The risk of adverse events among patients with AF were analyzed and compared with that of age- and sex-matched patients without AF.

RESULTS: The incidence of AF in year 2011 was 1.51 per 1,000 person-years, with a lifetime risk of AF being appropriately 1 in 7 for subjects aged > 20 years. The prevalence of AF is estimated to be 4.01% in 2050. Compared with patients without AF, AF was associated with an increased risk of mortality (adjusted hazard ratio [aHR], 2.61), heart failure (aHR, 3.31), ischemic stroke (aHR, 3.34), dementia (aHR, 1.56), sudden cardiac death (aHR, 1.83), and myocardial infarction (aHR, 1.62); all P < .01. The risks of ischemic stroke, heart failure, and mortality were especially higher compared with patients without AF in the initial period (approximately 6 months) after AF was first diagnosed.

CONCLUSIONS: The burden of AF among Asian patients is increasing, with a lifetime risk of AF being 1 in 7. Optimized management of any associated comorbidities should be part of the holistic management approach for AF.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Chao TF, Liu CJ, Tuan TC, et al. Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study. Chest. 2017. PMID: 29017957. doi:10.1016/j.chest.2017.10.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。